Newsletter SignupSearch

Transforming Concussion Care

Cohen Veterans Bioscience and the Brain Trauma Foundation are two nonprofits dedicated to advancing brain health. We are teaming up to set a new standard of care for our nation’s Veterans, active-duty service members, and millions of civilians worldwide who are affected by traumatic brain injury (TBI), including concussion. Together, we can find new ways to reduce patient symptoms, build tools for clinicians, and improve evidence-based guidelines.

Watch this webinar for insights and updates on brain injury treatment approaches from experts at Cohen Veterans Bioscience and the Brain Trauma Foundation.

We invite you to learn more about the Brain Trauma Blueprint, which identifies research priorities and fosters collaboration across the research, healthcare, and policy communities to advance precision diagnostics and tailored therapeutics for survivors of brain trauma. Our shared mission is to improve the lives of all individuals with TBI.

Learn More

Webinar originally hosted November 18, 2021
Watch Webinar

Magali Haas, MD, PhD
CEO & President, Cohen Veterans Bioscience

Dr. Haas is founder of Cohen Veterans Bioscience (CVB), a global organization that leads pioneering efforts in PTSD and TBI research, including clinical trials, biotechnology, genetics, and biomarker discovery. She has more than 15 years of pharmaceutical leadership experience in neuroscience clinical development, translational medicine, and diagnostics, primarily at J&J. Dr. Haas has spearheaded the Brain Trauma Blueprint initiative to establish a national roadmap for PTSD & TBI precision therapeutics research.

Jamshid Ghajar, MD, PhD, FACS
President Emeritus, Brain Trauma Foundation

Dr. Ghajar is a board-certified neurosurgeon. In 2014, he joined the neurosurgery faculty at Stanford, where he is a clinical professor of neurosurgery and the Moghadam Family Director of the Stanford Brain Performance Center, Stanford University School of Medicine. He founded the Brain Trauma Foundation to develop and implement best practice guidelines for TBI, with the goal of improving patients’ lives.

Frank Larkin, 40th U.S., Senate Sergeant at Arms (Ret.),
U.S. Navy SEAL (Ret.)

Chair, Cohen Veterans Bioscience Veterans Advisory Council

Frank Larkin served as a Navy SEAL from 1975 to 1981. He then worked as a police officer, homicide detective, and peace officer–flight paramedic. In 1984 he joined the United States Secret Service as a special agent. He served in the Presidential Protection Division and retired from the Secret Service in 2006. From 2015 to 2018, he served as the 40th Sergeant at Arms of the United States Senate. Having experienced the impact of military trauma both professionally and personally, Mr. Larkin is committed to improving Veterans’ healthcare.

More Webinars

Pathway and Network Based Discovery of Gene Signatures
ALS Patients Being PRO-ACTive: Can ALS Big Data Bring the Next ALS Breakthrough
Collaborative bottom-up modeling in computational biomedicine